Association of apolipoprotein e genetic variation in alzheimer's disease in indian population: A meta-analysis

American Journal of Alzheimer's Disease and other Dementias

Volumn 29, Issue 7, 2014, Pages 575-582

  Agarwal, Rachna ^a   Tripathi, Chandra Bhushan ^a  

^a INSTITUTE OF HUMAN BEHAVIOUR AND ALLIED SCIENCES   (India)

Author keywords

AD; ApoE; meta analysis; polymorphism

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

ALLELE; ALZHEIMER DISEASE; AMERICAN INDIAN; ARTICLE; CITATION ANALYSIS; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MULTIINFARCT DEMENTIA; ONSET AGE; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; CASE CONTROL STUDY; ETHNOLOGY; GENETIC POLYMORPHISM; GENETICS; HOMOZYGOTE; INDIA; META ANALYSIS; RISK ASSESSMENT;

ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; GENOTYPE; HOMOZYGOTE; HUMANS; INDIA; POLYMORPHISM, GENETIC; RISK ASSESSMENT;

EID: 84911095004     PISSN: 15333175     EISSN: 19382731     Source Type: Journal    
DOI: 10.1177/1533317514531443     Document Type: Article

References (46)

1. Romas SN, Tang MX, Berglund L, Mayeux R. ApoE genotype, plasma lipids, lipoproteins and AD in community elderly. Neurology. 1999 ; 53 (3). 517-521
2. Agarwal R, Chhillar N, Mishra VN, Tripathi CB. CSF tau and amyloid 42 levels in Alzheimer's disease - a meta analysis. Adv Alzheimers Dis. 2012 ; 1 (3). 30-44
3. Zekry D, Duyckaerts C, Belmin J, Geoffre C, Moulias R, Hauw JJ. Alzheimer's disease and brain infarcts in the elderly. Agreement with neuropathology. J Neurol. 2002 ; 249 (11). 1529-1534
4. Ahn JS, Ahn K, Kim JH, et al. ApoE-epsilon4 dependent association of the choline acetyltransferase gene polymorphisms (2,384 G > A & 1,882 G > A) with Alzheimer's disease. Clin Chem Acta. 2006 ; 368 (1-2). 179-182
5. Altamura C, Squitti R, Pasqualetti P, et al. What is the relationship among atherosclerosis markers, apolipoprotein E polymorphism and dementia?. Eur J Neurol. 2007 ; 14 (6). 679-682
6. Farrer LA, Cupples LA, Haines JL, et al. For the APOE and Alzheimer's disease meta analysis consortium: effects of age, sex and ethnicity on the association between apolipoprotein E genotype and Alzheimer's disease: a meta analysis. JAMA. 1997 ; 278 (16). 1349-1356
7. Evans RM, Hui S, Perkins A, lahiri DK, Poirier J, Farlow MR. Cholesterol and APOE genotype interact to influence Alzheimer's disease progression. Neurology. 2004 ; 62 (10). 1869-1871
8. Caselli RJ, Graff-Radford NR, Reima EM, et al. Preclinical memory decline in cognitively normal apolipoprotein E-L4 homozygotes. Neurology. 1999 ; 53 (1). 201-207
9. Craft S, Teri L, Edland SD, Kukull WA, et al. Accelerated decline in apolipoprotein E-ε4 homozygotes with Alzheimer's disease. Neurology. 1998 ; 51 (1). 149-153
10. Seshadri S, Drachman DA, Lippa CF. Apolipoprotein Eε4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know. Arch Neurol. 1995 ; 52 (11). 1074-1079
11. Bales KR, Verina T, Cummins DJ, et al. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. Proc Natl Acad Sci USA. 1999 ; 96 (26). 15233-15238
12. Dietschy JM, Turley SD. Cholesterol metabolism in the brain. Curr Opin Lipidol. 2001 ; 12 (2). 105-112
13. Reily SL, Ferrell RE, Kottke BA, Kamboh MI, Sing CF. The gender specific apolipoprotein E genotype influence on the distribution of lipids and apolipoproteins in the population of Rochester, MN. I Pleiotropic effects on means and variances. Am J Hum Genet. 1991 ; 49 (6). 1155-1166
14. Puglielli L, Tanzi RE, Koovacs DM. Alzheimer's disease: the cholesterol connection. Nat Neurosci. 2003 ; 6 (4). 345-351
15. Wu CW, Liao PC, Lin C, et al. Brain region-dependent increases in amyloid and apolipoprotein E levels in hypercholesterolemic rabbits. J Neural Transm. 2003 ; 110 (6). 641-649
16. Lane RM. Farlow MR. lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease. J lipid Res. 2005 ; 46 (5). 949-968
17. Ward A, Crean S, Catherine JM, et al. Prevalence of apolipoprotein E4 genotype and homozygotes, (APO E e4/4) among patients diagnosed with Alzheimer's disease: a systematic review and meta analysis. Neuroepidemiology. 2012 ; 38 (1). 1-17
18. Singh NK, Chhillar N, Banerjee BD, et al. Gene-environment interaction in Alzheimer's disease. Am J Alzheimers Dis Other Dement. 2012 ; 27 (7). 496-503
19. Asada T, Motonaga T, Kinoshita T. Predictors of severity of behavioral disturbance among Community-dwelling elderly individuals with Alzheimer's disease: a 6-year follow up study. Psychiatry Clin Neurosci. 2000 ; 54 (6). 673-677
20. Chandra V, Ganguli M, Pandav R, Johnston J, Belle S, DeKosky ST. Prevalence of Alzheimer's disease and other dementias in rural India. Neurology. 1998 ; 51 (4). 1000-1008
21. Ganguli M, Chandra V, Kamboh MI, et al. Apolipoprotein E polymorphism and Alzheimer's disease: the Indo-US cross-national dementia study. Arch Neurol. 2000 ; 57 (6). 824-830
22. Hallman DM, Boerwinkle E, Saha N, et al. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine population. Am J Hum Genet. 1991 ; 49 (2). 338-349
23. Jack CR, Albert MS, Knopman DS, et al. Introduction to the recommendations from the National Institute on Aging. Alzheimer's association work groups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011 ; 7 (3). 257-262
24. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994 ; 50 (4). 1088-1101
25. Kandimalla RJL, Prabhakar S, Binukumar BK, et al. Apo-E ε4 allele in conjunction with A42 and Tau in CSF: biomarkers for Alzheimer's disease. Curr Alzheimer Res. 2011 ; 8 (2). 187-196
26. Mansoori N, Tripathi M, Alam R, et al. IL-6-174 G/C and ApoE gene polymorphisms in Alzheimer's and vascular dementia patients attending the cognitive disorder clinic of the all India institute of medical sciences, New Delhi. Demet Geriatr Cogn Disord. 2010 ; 30 (6). 461-468
27. Bharath S, Purushottam M, Mukherjee O, et al. Apolipoprotein e polymorphism and Dementia: a hospital-based study from Southern India. Demet Geriatr Cogn Disord. 2010 ; 30 (6). 455-460
28. Kapur S, Sharad S, Kapoor M, Bala K. Apo E genotypes: risk factor for Alzheimer's disease. J Indian Acad Clin Med. 2006 ; 7 (2). 118-112
29. Luthra K, Tripathi M, Grover R, Dwivedi M, Kumar A, Dey AB. Apolipoprotein E gene polymorphism in Indian patients with Alzheimer's disease and Indian patients with Alzheimer's disease and vascular Dementia. Dement Geriatr Cogn Disord. 2004 ; 17 (3). 132-135
30. Chandak GR, Uma Dridevi M, vas CJ, Pannikker DM, Singh L. Apolipoprotein E and presenilin-1 allelic variation and Alzheimer's disease in India. Hum Biol. 2002 ; 74 (5). 683-693
31. Shaji S, Promodu K, Abraham T, Roy KJ, Verghase A. An epidemiological study of dementia in a rural community in Kerala, India. Br J Psychiatry. 1996 ; 168 (6). 745-749
32. Van CJ, Pinto C, Panikker D, et al. Prevalence of dementia in an urban India population. Int Psychogeriatr. 2001 ; 13 (4). 439-450
33. Raygani AV, Zahrai M, Raygani AV, et al. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran. Neurosci Lett. 2005 ; 375 (1). 1-6
34. Kim KW, Jhoo JH, Lee KU, et al. Association between apolipoprotein E polymorphism and Alzheimer's disease in Koreans. Neurosci Lett. 1999 ; 277 (3). 145-148
35. Tang M-X, Maestre G, Tsai WT, et al. Relative risk of Alzheimer's disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. Am J Human Genet. 1996 ; 58 (3). 574-584
36. De-andrade FM, Larrandaburu M, Callegari-Jacques SM, Gastaldo G, Hutz MH. Association of apolipoprotein E polymorphism with plasma lipids and Alzheimer's disease in a Southern Brazilian population. Braz J Med Biol Res. 2000 ; 33 (5). 529-537
37. Bickeböller H, Campion D, Brice A, et al. Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex. Am J Hum Genet. 1997 ; 60 (2). 439-446
38. Farrer LA, Cupples LA, Haines JL, et al. The effect of age, sex and ethnicity on the association between apolipoprotein E genotype and Alzheimer's disease. A meta analysis. JAMA. 1997 ; 278 (16). 1349-1356
39. Frisoni GB, Manfredi M, Geroldi C, et al. The prevalence of apo E-epsilon 4 in Alzheimer's disease is age dependent. J Neurol Neurosurg Psychiatry. 1998 ; 65 (1). 103-106
40. Evans RM, Emsley CL, Gao S, et al. Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: a population-based study of African Americans.. Neurology. 2000 ; 54 (1). 240-242
41. Pandey P, Pradhan S, Mittal B. Presenilin gene predisposes to late-onset degenerative but not vascular dementia: a comparative study of PS1 and ApoE genes in a North Indian cohort. Dement Geriatr Cogn Disord. 2007 ; 24 (3). 151-161
42. Bang OY, Kwak YT, Joo IS, Huh K. Important link between dementia subtype and apolipoprotein E: a Meta-analysis. Yonsei Med J. 2003 ; 44 (3). 401-413
43. Apolipoprotein E genotype in Alzheimer's disease. Lancet. 1996 ; 347 (9008). 1091-1095
44. Rubinsztein DC, Eastern DF. Apolipoprotein E genetic variation and Alzheimer's disease. Dement Geriatr Cogn Disord. 1999 ; 10 (3). 199-209
45. Small BJ, Rosnick CB, Fratiglioni L, Backman L. Apolipoprotein e and cognitive performance: a meta analysis. Psychol Aging. 2004 ; 19 (4). 592-600
46. Wisdom NM, Callaham JL, Hawkins KA. The effects of apolipoprotein E on non-impaired cognitive functioning: a meta-analysis. Neurobiol Aging. 2011 ; 32 (1). 63-74